Structure Database (LMSD)

Introduction | Text/ontology-based search | Structure-based search | Programmatic Access

LMSD: Lipid classification search results

Sphingolipids [SP] (W) --> Neutral glycosphingolipids [SP05]--> Simple Glc series [SP0501]
LM_IDCommon NameSystematic NameFormulaMass
LMSP05010031Glucosyl sphingosine1-β-glucosyl-sphing-4-enineC24H47NO7461.3353
LMSP05010032FMC-5(d18:1/18:0)N-(octadecanoyl)-1-β-(2',3',4',6'-
tetra-O-acetyl-galactosyl)-3-O-acetyl-
sphing-4-enine
C52H91NO13937.6490
LMSP05010033FMC-5(d18:1/20:0)N-(eicosanoyl)-1-β-(2',3',4',6'-tetra-
O-acetyl-galactosyl)-3-O-acetyl-sphing-
4-enine
C54H95NO13965.6803
LMSP05010034FMC-5(d18:1/22:0)N-(docosanoyl)-1-β-(2',3',4',6'-tetra-
O-acetyl-galactosyl)-3-O-acetyl-sphing-
4-enine
C56H99NO13993.7116
LMSP05010035FMC-5(d18:1/24:0)N-(tetracosanoyl)-1-β-(2',3',4',6'-
tetra-O-acetyl-galactosyl)-3-O-acetyl-
sphing-4-enine
C58H103NO131021.7429
LMSP05010036FMC-5(d18:1/24:1)N-(15Z-tetracosenoyl)-1-β-(2',3',4',
6'-tetra-O-acetyl-galactosyl)-3-O-
acetyl-sphing-4-enine
C58H101NO131019.7273
LMSP05010037FMC-6(d18:1/24:0(2-OH))N-(2-hydroxy-tetracosanoyl)-1-β-(2',
3',4',6'-tetra-O-acetyl-galactosyl)-3-
O-acetyl-sphing-4-enine
C58H103NO141037.7379
LMSP05010038FMC-6(d18:1/22:0(2-OH))N-(2-hydroxy-docosanoyl)-1-β-(2',3',
4',6'-tetra-O-acetyl-galactosyl)-3-O-
acetyl-sphing-4-enine
C56H99NO141009.7066
LMSP05010039Phalluside-1N-(2R-hydroxy-hexadecanoyl)-1-β-
glucosyl-9-methyl-sphing-4E,8E,10E-
trienine
C41H75NO9725.5442
LMSP05010040Dracontioside AN-(2R-hydroxyoctadecanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
C42H79NO9741.5755
LMSP05010041Dracontioside BN-(2R-hydroxytetracosanoyl)-1-β-
glucosyl-4R-hydroxy-8Z-
octadecasphingenine
C48H93NO10843.6799
LMSP05010042GlcCer(t18:1(8Z)/16:0(2OH[S]))N-(2R-hydroxyhexadecanoyl)-1-β-
glucosyl-4R-hydroxy-8Z-
octadecasphingenine
C40H77NO10731.5547
LMSP05010043GlcCer(t18:1(8Z)/18:0(2OH[S]))N-(2R-hydroxyoctadecanoyl)-1-β-
glucosyl-4R-hydroxy-8Z-
octadecasphingenine
C42H81NO10759.5860
LMSP05010044GlcCer(t18:1(8Z)/20:0(2OH[S]))N-(2R-hydroxyeicosanoyl)-1-β-glucosyl-
4R-hydroxy-8Z-octadecasphingenine
C44H85NO10787.6173
LMSP05010045GlcCer(t18:1(8Z)/22:0(2OH[S]))N-(2R-hydroxydocosanoyl)-1-β-glucosyl-
4R-hydroxy-8Z-octadecasphingenine
C46H89NO10815.6486
LMSP05010046GlcCer(d18:1(8Z)/25:0(2OH[R]))N-(2R-hydroxypentacosanoyl)-1-β-
glucosyl-4R-hydroxy-8Z-
octadecasphingenine
C49H95NO10857.6956
LMSP05010047GlcCer(t18:1(8Z)/26:0(2OH[R]))N-(2R-hydroxyhexacosanoyl)-1-β-
glucosyl-4R-hydroxy-8Z-
octadecasphingenine
C50H97NO10871.7112
LMSP05010048GlcCer(d18:2(4E,8Z)/16:0(2OH[R]))N-(2R-hydroxyhexadecanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
C40H75NO9713.5442
LMSP05010049GlcCer(d18:2(4E,8Z)/17:0(2OH[R]))N-(2R-hydroxyheptadecanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
C41H77NO9727.5598
LMSP05010050GlcCer(d18:2(4E,8Z)/18:0(2OH[R]))N-(2R-hydroxyoctadecanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
C42H79NO9741.5755
LMSP05010051GlcCer(d18:2(4E,8Z)/19:0(2OH[R]))N-(2R-hydroxynonadecanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
C43H81NO9755.5911
LMSP05010052GlcCer(d18:2(4E,8Z)/20:0(2OH[R]))N-(2R-hydroxyeicosanoyl)-1-β-glucosyl-
4E,8Z-octadecasphingdienine
C44H83NO9769.6068
LMSP05010053GlcCer(d18:2(4E,8Z)/21:0(2OH[R]))N-(2R-hydroxyheneicosanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
C45H85NO9783.6224
LMSP05010055GlcCer(d18:2(4E,8Z)/22:0(2OH[R]))N-(2R-hydroxydocosanoyl)-1-β-glucosyl-
4E,8Z-octadecasphingadienine
C46H87NO9797.6381
LMSP05010056GlcCer(d18:2(4E,8Z)/24:0(2OH[R]))N-(2R-hydroxytetracosanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
C42H81NO4663.6166
LMSP05010057GlcCer(d18:2(4E,8Z)/25:0(2OH[R]))N-(2R-hydroxypentacosanoyl)-1-β-
glucosyl-4E,8Z-octadecasphingadienine
C49H93NO9839.6850
LMSP05010058GlcCer(t18:1(8E)/24:0(2OH[R]))N-(2R-hydroxytetracosanoyl)-1-β-
glucosyl-4R-hydroxy-8E-
octadecasphingenine
C48H93NO10843.6799
LMSP05010059GlcCer(d21:1(8E)(9Me)/15:0(2OH[R]))N-(2R-hydroxypentadecanoyl)-1-β-
glucosyl-9-methyl-8E-
heneicosasphingenine
C43H83NO9757.6068
LMSP05010060GlcCer(d18:1(8E)/18:0(2OH[R]))N-(2R-hydroxyoctadecanoyl)-1-β-
glucosyl-8E-octadecasphingenine
C42H81NO9743.5911
LMSP05010061GlcCer(d18:1(8E)/21:0(2OH[R]))N-(2R-hydroxyheneicosanoyl)-1-β-
glucosyl-8E-octadecasphingenine
C45H87NO9785.6381
LMSP05010062GlcCer(d18:1(8E)/22:0(2OH[R]))N-(2R-hydroxydocosanoyl)-1-β-glucosyl-
8E-octadecasphingenine
C46H89NO9799.6537
LMSP05010063GlcCer(d18:1(8E)/24:0(2OH[R]))N-(2R-hydroxytetracosanoyl)-1-β-
glucosyl-8E-octadecasphingenine
C48H93NO9827.6850
LMSP05010064GlcCer(d18:2(4E,8E)/16:0(2OH[R]))N-(2R-hydroxyhexadecanoyl)-1-β-
glucosyl-4E,8E-octadecasphingadienine
C40H75NO9713.5442
LMSP05010065GlcCer(d18:2(4E,8E)/20:0(2OH[R]))N-(2R-hydroxyicosanoyl)-1-β-glucosyl-
4E,8E-octadecasphingadienine
C44H83NO9769.6068
LMSP05010066GlcCer(d18:2(4E,8E)/18:0(2OH[R]))N-(2R-hydroxyoctadecanoyl)-1-β-
glucosyl-4E,8E-octadecasphingadienine
C42H79NO9741.5755
LMSP05010067GlcCer(d18:2(4E,8E)/24:0(2OH[R]))N-(2R-hydroxytetracosanoyl)-1-β-
glucosyl-4E,8E-octadecasphingadienine
C48H91NO9825.6694
LMSP05010068GlcCer(d18:1(8Z)/16:0(2OH[R]))N-(2R-hydroxyhexadecanoyl)-1-β-
glucosyl-8Z-octadecasphingenine
C40H77NO9715.5598
LMSP05010069GlcCer(d18:1(8Z)/18:0(2OH[R]))N-(2R-hydroxyoctadecanoyl)-1-β-
glucosyl-8Z-octadecasphingenine
C42H81NO9743.5911
LMSP05010070GlcCer(d18:1(8Z)/20:0(2OH[R]))N-(2R-hydroxyicosanoyl)-1-β-glucosyl-
8Z-octadecasphingenine
C44H85NO9771.6224
LMSP05010071GlcCer(d18:1(8Z)/21:0(2OH[R]))N-(2R-hydroxyheneicosanoyl)-1-β-
glucosyl-8Z-octadecasphingenine
C45H87NO9785.6381
LMSP05010072GlcCer(d18:1(8Z)/22:0(2OH[R]))N-(2R-hydroxydocosanoyl)-1-β-glucosyl-
8Z-octadecasphingenine
C46H89NO9799.6537
LMSP05010073GlcCer(d18:1(8Z)/24:0(2OH[R]))N-(2R-hydroxytetracosanoyl)-1-β-
glucosyl-8Z-octadecasphingenine
C48H93NO9827.6850
LMSP05010074GlcCer(d18:2(4E,8Z)/24:0(2OH[R]))N-(2R-hydroxydocosanoyl)-1-β-glucosyl-
4E,8Z-octadecasphingadienine
C48H91NO9825.6694
LMSP05010075GlcCer(d18:0/16:0(2OH[R]))N-(2R-hydroxyhexadecanoyl)-1-β-
glucosyl-octadecasphinganine
C40H79NO9717.5755
LMSP05010076GlcCer(d18:0/20:0(2OH[R]))N-(2R-hydroxyeicosanoyl)-1-β-glucosyl-
octadecasphinganine
C44H87NO9773.6381
LMSP0501AA00GlcCer (W)Glcβ-Cer--
LMSP0501AA01GlcCer(d18:1/12:0)N-(dodecanoyl)-1-β-glucosyl-sphing-4-
enine
C36H69NO8643.5023
LMSP0501AA03GlcCer(d18:1/16:0)N-(hexadecanoyl)-1-β-glucosyl-sphing-
4-enine
C40H77NO8699.5649
LMSP0501AA04GlcCer(d18:0/16:0)N-(hexadecanoyl)-1-β-glucosyl-
sphinganine
C40H79NO8701.5806
LMSP0501AA05GlcCer(d18:1/18:0)N-(octadecanoyl)-1-β-glucosyl-sphing-
4-enine
C42H81NO8727.5962

Showing page 1 of 4     Results:    1  2  3  4  Next     Showing results 1 to 50 of 179

   

logo LIPID MAPS is funded by a Wellcome Trust.